WannaCry, Petya, GoldenEye ... for some years now malware has been threatening the IT infrastructure of companies worldwide. The latest attacks have already caused major damages - even at some global players. The fact that they had only a "limited" impact and did not completely paralyse entire companies was due to a few "design failures". The question is, therefore, whether the IT infrastructure has to be reconsidered to face the growing IT threats? Please read more here

Last December, the webinar GMP Update summarized the latest "innovations" and "changes" in the GMP environment. In part II of this article, you will find out more about the developments in clinical trials, water for injection purposes, process validation for biotechnological products, ATMPs or data integrity in the current year. Please read more here

The systematic evaluation of the Warning Letters sent by the US FDA to pharmaceutical companies or API manufacturers in recent years shows that the agency's focus is shifting again and again. The evaluation of the "Blue Letters" for the year 2016 revealed a surprise in several respects. Please read more here

Just like almost anywhere else, informatics is the normality in lab operations. Data intensive analytics create gapless knowledge management systems also facilitating the cross-sectoral collaboration. The trends in data integrity, security and in the current regulatory requirements were in the centre of interest during the lab informatics updates at the PharmaLab Congresses of the last two years. Please read more here